Real-World Evaluation of a Pharmacoinvasive Strategy for STEMI in Latin America: A Cost-Effective Approach with Short-Term Benefits.

2 Interestingly, our study showed a lower incidence of MACE at 30 days in the PI group, although it did not reach statistical significance in the cohort as previous trials suggested. 2 Regarding major bleeding events, no differences were found between groups in terms of BARC ≥3 criteria, which in our cohort were lower than in the STREAM study (21.8% vs 20.2%); as expected, a higher incidence of this endpoint was seen in comparison with an NR strategy. 2 Although primary coronary intervention is the preferred reperfusion strategy in STEMI within the first hours of symptom onset, its superiority has been demonstrated in high-volume centers in developed countries.

also in 111,027 other papers